ZEALAND PHARMA
RegistradaNominativa · Brasil
Marca registrada: vale avaliar o risco de conflito
A marca "ZEALAND PHARMA" está registrada no Brasil. Se você usa ou pretende usar um nome similar, pode haver risco de conflito. Vale olhar classes, histórico e despachos antes de decidir o próximo passo.
Panorama da marca
- Situação INPI
- Concessão de registro em designação
- Tramitação até registro
- 1 ano e 6 meses
- Eventos no processo
- 3
- Última atualização
- 28 de abril de 2026
Dados do processo
- Titular
- ZEALAND PHARMA A/S
- Número do processo
- 501831920
- Número de registro
- 501831920
- Natureza
- Madri Produto/Serviço
- Data do depósito
- 29 de outubro de 2024
- Data do registro
- 28 de abril de 2026
- Válido até
- 29 de outubro de 2034
Produtos e serviços cobertos
Pharmaceutical preparations for medical purposes; synthetic peptides for pharmaceuticals purposes; pharmaceutical preparations for the treatment of diseases, illnesses and ailments in humans, such as pharmaceutical preparations for treating endocrine disorders, immunity disorders, nutritional and metabolic diseases, such as diabetes and obesity; pharmaceutical preparations for the treatment and prevention of hypoglycemia; hypoglycemic agents; medical preparations in the nature of a liquid solution for medical purposes for the treatment and prevention of hypoglycemia; pharmaceutical preparations for treating gastrointestinal diseases, such as short bowel syndrome and ulcerative colitis; pharmaceutical preparations altering the immune system, such as complement inhibitors; apparatus and instruments containing pharmaceutical preparations, substances and medicines; medical rescue injection pens containing glucagon to treat severe cases of low blood sugar; pre-filled syringes for medical purposes.;
Computer software, including application software for smartphones [mobile phones], for tablet computers and other handheld or portable personal computers and for personal computers, all for determining treatment recommendations, dose calculation and patient support programs in the nature of providing medical information; databases and software, including application software and databases for use in connection with medical diagnosing, treatment, treatment planning and patient support programs; downloadable software configured for insulin monitoring and tracking blood glucose levels; downloadable software configured for the collection, editing, organizing, modifying, book marking, transmission, storage, sharing and analysis of data and information in the field of diabetes management; wearable devices for insulin monitoring; computer hardware and software for use with medical injection devices for collecting, transmitting and displaying medical data; medical software for the management of diabetes, obesity or gastrointestinal diseases; electronic publications, namely, leaflets, books, booklets, handouts, magazines as well as medical, instructional and teaching material in the field of diabetes, obesity and gastrointestinal diseases.;
Instruments and apparatus for administering pharmaceuticals; medical devices, namely, diabetes management devices, infusion and injection devices, infusion pumps, infusion pump controllers and parts and attachments thereof; medical devices and sensors used to continuously monitor the concentration of glucose in the human body; glucose monitors; glucose monitor accessories, namely, transmitters, receivers, and medical sensor insertion devices; wearable medical devices for insulin monitoring; infusion pumps for improvement of glycemic control and auto-injector pens for the treatment of hypoglycemia; medical rescue injection pens for administrating glucagon; parts and accessories for all the aforesaid goods.;
Scientific and technological services and research and design relating thereto in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; industrial analysis and research services in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; medical, biological, biotechnological, genetic, laboratory and pharmaceutical research, design and development services; laboratory research in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; information and consultancy services relating to all the aforesaid; providing scientific information on diabetes, obesity and gastrointestinal diseases; hosting of websites and mobile apps in relation to technology that enables users to record, track, and generate reports regarding the condition, treatment and the management of diabetes, obesity and gastrointestinal diseases; computer services, namely providing access to data concerning medical analysis and management of diabetes, obesity and gastrointestinal diseases; clinical trials.;
Medical services; medical analysis services for the diagnosis and treatment of humans; medical consulting services in the field of diseases, illnesses and ailments in humans; medical services related to the testing and treatment of patients with diabetes or low blood sugar (hypoglycemia); medical services related to testing and treatment of patients with gastrointestinal diseases, such as short bowel syndrome and ulcerative colitis; medical consulting services, namely, providing patient adherence programs to patients suffering from diabetes, obesity or gastrointestinal diseases; providing medical information via a website that provide a patient adherence program to patients suffering from diabetes, obesity or gastrointestinal diseases; medical information services, namely, providing information relating to the treatment of diabetes, obesity or gastrointestinal diseases; medical advisory services, namely providing advisory services relating to the treatment of diabetes, obesity or gastrointestinal diseases; medical services in the nature of patient support relating to the treatment of diabetes, obesity or gastrointestinal diseases; medical information and advice in relation to treatment planning, including information and advice provided via the Internet, databases and application software; consultancy services relating to the aforesaid.;
Linha do tempo do processo
3 eventosMovimentações mais recentes da marca “ZEALAND PHARMA” publicadas na Revista da Propriedade Industrial (RPI). O detalhe de cada despacho fica na consulta completa.
- Concessão / deferimento28 de abr. de 2026RPI 2886
Concessão de registro em designação
Detalhes na consulta completa - Ação / prazo24 de jun. de 2025RPI 2842
Publicação de pedido de registro para oposição (exame formal de designação concluído)
Detalhes na consulta completa
O que fazer se a sua marca se aproxima de "ZEALAND PHARMA"?
Conflitos de marcas no Brasil são resolvidos com base na anterioridade do depósito, nas classes de Nice e no segmento de atuação. O processo tem várias fases e pode ficar complexo quando o nome é parecido ou o mercado se cruza. Uma leitura cuidadosa ajuda a decidir se vale seguir, ajustar ou recuar.
A TrademarkIQ cruza histórico, decisões e padrões de aprovação por classe e setor em uma base com +6 milhões de processos brasileiros. Isso ajuda a enxergar o risco com mais contexto e a encontrar o melhor caminho comercial e jurídico para a sua marca.
Marcas semelhantes
Outros processos no INPI com nome próximo de "ZEALAND PHARMA".
Outras marcas do titular
Processos de marca no INPI em nome de Zealand Pharma A/s.
Escritórios especializados
Reference Registro de Marcas ltda
Anel Marcas e Patentes ltda
Ariboni, Fabbri e Schmidt Sociedade de Advogados
Vigilância de marca
Seja avisado antes que vire problema
Monitoramento contínuo: receba um alerta a cada novo depósito que possa colidir com ZEALAND PHARMA ou com a sua marca — a tempo de se opor dentro do prazo.
Monitorar marcaDados actualizados a partir de uma base com +6 milhões de marcas brasileiras analisadas. Esta página é informativa e não substitui parecer jurídico, mas ajuda a orientar a decisão com mais contexto comercial e técnico.
